Paasa Logo
Pharmarise Holdings Corporation logo
2796JPXMarket closedOpens 9:00am JST

Pharmarise Holdings Corporation

¥507.00Last updated
+¥2.00 (0.40%)Past day
Timezone

Pharmarise Holdings Corporation (JPX: 2796) is trading at ¥507.00, about ₹309 at today's JPY/INR rate, as of 30 Sep 2026, 2:30 AM ET, up 0.40% today. Indian residents can buy Pharmarise from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:¥505.00
Previous close:¥505.00
Volume:5.50K

Today's low

¥505.00

Today's high

¥510.00

52 week low

¥471.00

52 week high

¥554.00

2796 opened at ¥505.00, closed previously at ¥505.00, and has traded between ¥471.00 and ¥554.00 over the past 52 weeks.

About

Pharmarise Holdings Corporation predominantly oversees a chain of pharmacies that dispense prescription medications throughout Japan. These establishments fulfill prescriptions provided by medical facilities, offering vital pharmaceutical services to patients. Beyond its primary dispensing activities, the company also manages drugstores and convenience stores, and retails cosmetic products. Additionally, it provides services including the safekeeping and administration of patient medical records for healthcare institutions, operates medical complex centers, and offers temporary staffing assistance. As of May 31, 2021, the corporation maintained a network of 347 outlets. Pharmarise Holdings Corporation was founded in 1984 and its main office is located in Tokyo, Japan.

Country
JP
CEO
Masayuki Akiyama
Exchange listed on
JPX
Industry
Medical - Pharmaceuticals
Base currency
JPY
Full Time Employees
2,031
Sector
Healthcare
IPO date
21/02/2007

Key statistics

Avg. volume

9.66K

Market cap

¥5.83B

P/E Ratio

59.72

Price-to-sales ratio

0.08

Enterprise value

¥14.92B

Free cash flow yield

44.63%

Debt-to-equity ratio

2.08

Return on equity

1.65%

ROIC

0.64%

Beta

0.24

Dividend yield

2.76%

Last dividend

¥14.00

Financial overview

Revenue

¥69.51B

Earnings per share

¥9.95

Free cash flow

¥2.58B

Net profit margin

0.14%

Gross margin

12.31%

EBITDA

¥2.58B

Revenue growth

9.45%

Similar securities

This is not an investment recommendation

How to buy Pharmarise from India

Indian residents can buy Pharmarise shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.

  3. Search for Pharmarise and place an order

    Find Pharmarise by name or by its ticker, 2796, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Pharmarise trades 5:30 am – 12:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Pharmarise position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Pharmarise from India

Trading and taxes when buying Pharmarise from India

Trading and limits

Trading hours
9:00 am – 3:30 pm JST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Pharmarise’s current yield is 2.76%.Dividend tax explained
Estate or inheritance tax
May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Pharmarise stock?

Yes. Pharmarise (2796) has been listed on the Tokyo Stock Exchange since 2007, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Pharmarise share cost in rupees?

One Pharmarise share is ¥507.00 — about ₹309 at a JPY/INR rate of 0.6103 on 29 Sep 2026. Both the Pharmarise price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Pharmarise from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Pharmarise?

The Tokyo Stock Exchange typically trades in units of 100 shares.

How are gains on Pharmarise shares taxed in India?

Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Pharmarise price. Paasa issues a capital-gains statement for your return.

Does Pharmarise pay a dividend, and how is it taxed in India?

Yes. Pharmarise pays a dividend and the current yield is 2.76%; the last declared dividend was ¥14.00 per share, about ₹8.54. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Pharmarise from India?

The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.

Is there estate or inheritance tax on Pharmarise shares held from India?

Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.

Do I have to declare Pharmarise shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Pharmarise holding, its cost and its closing value.

How do I sell Pharmarise and bring the money back to India?

You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.